Session Submission Summary
Share...

Direct link:

Evaluating Policies to Improve Access to Contraception in the US

Saturday, November 7, 3:30 to 5:00pm, Property: Boston Marriott Copley Place, Floor: 3rd Floor, Room: Clarendon

Session Submission Type: Panel

Abstract

Access to the full range of contraceptive methods is necessary to ensure reproductive health and autonomy by providing all people methods to determine whether, when, and under what circumstances to become pregnant. Better access to contraception is associated with reduced risk of unwanted pregnancy and pregnancy-related morbidity and mortality, and is cost-saving for healthcare payers. More than a decade after the Affordable Care Act (ACA) required insurance coverage of nearly all contraceptive methods without cost-sharing, there are still significant barriers to access. For example, in a 2024 survey of US females of reproductive age, nearly one-quarter reported that they were not using their preferred contraceptive method. This panel will feature four research studies that shed light on how state-level policies, and implementation of such policies, may improve access to contraception. The first study curates a state-quarter level Medicaid dataset and applies a Callaway-Sant'Anna difference-in-differences estimator to evaluate state-level policies requiring Medicaid to cover extended supply of contraception (i.e., 12 months of contraceptive pills at a single prescription fill). The second study applies a quasi-experimental difference-in-differences analysis to estimate the effects of a Massachusetts statewide standing order allowing pharmacies to dispense emergency contraception including Ella and Plan B. The third study develops methods to quantify the contraceptive workforce in Medicaid administrative data, identifying the specialties of clinicians who prescribe contraception and identifying geographic variation in access to prescribers and the full range of contraceptive methods. The fourth study uses staggered difference-in-differences methods to estimate the impact of state laws that permit nurse practitioners and midwives full practice authority to prescribe medications, including contraception, on fertility. Taken together, findings from this work will offer participants a multi-faceted discussion about different state policy strategies to enhance access to contraception, as well as exploring how state-level, provider-level, and patient-level data can best be used to provide a comprehensive evaluation of these policies. The ultimate goal of the panel is to provide actionable evidence about how state policies can improve reproductive health.

Policy Area

Chair

Discussants

Organizer

Individual Presentations